Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : SARS-CoV-2

Virax Biolabs Secures ISO Certifications to Advance Long COVID Diagnostics

Virax Biolabs Secures ISO Certifications to Advance Long COVID Diagnostics
03/31/2026 | Companies
  Virax Biolabs Group Limited (NASDAQ: VRAX) announced that its fully owned subsidiary, Virax Biolabs (UK) Limited, has secured ISO 13485:2016 and ISO 9001:2015 certifications for its quality management systems. The certifications were granted by LRQA on 18 February 2026 and are valid through...
ADJUST Center, biotech news, clinical validation, diagnostics industry, Emory University, healthcare innovation, immunological assays, in vitro diagnostics, ISO 13485, ISO 9001, IVD development, laboratory developed test, LDT pathway, Long COVID, medical devices, PAIS, PASC, post-acute infection syndromes, quality management system, regulatory compliance, SARS-CoV-2, T cell profiling, U.S. clinical trials, Virax Biolabs, ViraxImmune, VRAX

Meet Gilead’s virologists as they hunt COVID-19 variants

Meet Gilead’s virologists as they hunt COVID-19 variants
01/20/2023 | Companies
When a new COVID-19 virus variant is discovered, Gilead virologists Charlotte Hedskog and John Bilello, along with their teams, mobilize as "variant hunters." Their mission is to see if COVID-19 therapeutics will still be effective against new strains. The process necessitates perseverance and...
antivirals, CDC, Centers for Disease Control, Charlotte Hedskog, Clinical Virology, COVID-19, COVID-19 therapeutics, Discovery Virology, genetic variants, Gilead, John Bilello, Researcher, SARS-CoV-2, Scientist, subvariants, therapeutic antibodies, transmission rate, vaccines, variant, variant hunters, virologists, Virology, virus strain, WHO, World Health Organization


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com